| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |